Literature DB >> 27720434

Pneumocystis infection alters the activation state of pulmonary macrophages.

Jessica M Deckman1, Cathryn J Kurkjian1, Joseph P McGillis1, Theodore J Cory2, Susan E Birket2, Linda M Schutzman3, Brian S Murphy3, Beth A Garvy1, David J Feola4.   

Abstract

Recent studies show a substantial incidence of Pneumocystis jirovecii colonization and infection in patients with chronic inflammatory lung conditions. However, little is known about the impact of Pneumocystis upon the regulation of pulmonary immunity. We demonstrate here that Pneumocystis polarizes macrophages towards an alternatively activated macrophage-like phenotype. Genetically engineered mice that lack the ability to signal through IL-4 and IL-13 were used to show that Pneumocystis alternative macrophage activation is dependent upon signaling through these cytokines. To determine whether Pneumocystis-induced macrophage polarization would impact subsequent immune responses, we infected mice with Pneumocystis and then challenged them with Pseudomonas aeruginosa 14 days later. In co-infected animals, a higher proportion of macrophages in the alveolar and interstitial spaces expressed both classical and alternatively activated markers and produced the regulatory cytokines TGFβ and IL-10, as well as higher arginase levels than in mice infected with P. aeruginosa alone. Our results suggest that Pneumocystis reprograms the overall macrophage repertoire in the lung to that of a more alternatively-activated setpoint, thereby altering subsequent immune responses. These data may help to explain the association between Pneumocystis infection and decline in pulmonary function.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Arginase; Inflammation; Macrophage; Pneumocystis

Mesh:

Substances:

Year:  2016        PMID: 27720434      PMCID: PMC5154897          DOI: 10.1016/j.imbio.2016.10.003

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  61 in total

1.  Murine CD4+ T lymphocyte subsets and host defense against Pneumocystis carinii.

Authors:  J E Shellito; C Tate; S Ruan; J Kolls
Journal:  J Infect Dis       Date:  2000-05-31       Impact factor: 5.226

2.  IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection.

Authors:  Mahboob H Qureshi; Allen G Harmsen; Beth A Garvy
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

3.  Type II monocytes modulate T cell-mediated central nervous system autoimmune disease.

Authors:  Martin S Weber; Thomas Prod'homme; Sawsan Youssef; Shannon E Dunn; Cynthia D Rundle; Linda Lee; Juan C Patarroyo; Olaf Stüve; Raymond A Sobel; Lawrence Steinman; Scott S Zamvil
Journal:  Nat Med       Date:  2007-08-05       Impact factor: 53.440

4.  Airway disease in upper and lower lobes in lungs of patients with and without emphysema.

Authors:  J L Wright; B J Wiggs; J C Hogg
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

5.  Pneumocystis carinii carriage among cystic fibrosis patients, as detected by nested PCR.

Authors:  A Sing; A M Geiger; M Hogardt; J Heesemann
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

6.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor.

Authors:  S M Russell; A D Keegan; N Harada; Y Nakamura; M Noguchi; P Leland; M C Friedmann; A Miyajima; R K Puri; W E Paul
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

7.  The absence of Hck, Fgr, and Lyn tyrosine kinases augments lung innate immune responses to Pneumocystis murina.

Authors:  Michael P Nelson; Allison E Metz; Shaoguang Li; Clifford A Lowell; Chad Steele
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

8.  Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.

Authors:  Jing Wang; Francis Gigliotti; Samir P Bhagwat; Thaddeus C George; Terry W Wright
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

9.  Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis.

Authors:  John T Pesce; Thirumalai R Ramalingam; Margaret M Mentink-Kane; Mark S Wilson; Karim C El Kasmi; Amber M Smith; Robert W Thompson; Allen W Cheever; Peter J Murray; Thomas A Wynn
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

10.  The interaction in vitro of Pneumocystis carinii with macrophages and L-cells.

Authors:  H Masur; T C Jones
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  7 in total

Review 1.  New advances in understanding the host immune response to Pneumocystis.

Authors:  J Claire Hoving; Jay K Kolls
Journal:  Curr Opin Microbiol       Date:  2017-11-12       Impact factor: 7.934

2.  Murine models of Pneumocystis infection recapitulate human primary immune disorders.

Authors:  Waleed Elsegeiny; Mingquan Zheng; Taylor Eddens; Richard L Gallo; Guixiang Dai; Giraldina Trevejo-Nunez; Patricia Castillo; Kara Kracinovsky; Hillary Cleveland; William Horne; Jonathan Franks; Derek Pociask; Mark Pilarski; John F Alcorn; Kong Chen; Jay K Kolls
Journal:  JCI Insight       Date:  2018-06-21

3.  Myeloid arginase-1 controls excessive inflammation and modulates T cell responses in Pseudomonas aeruginosa pneumonia.

Authors:  Dalia Haydar; Rene Gonzalez; Beth A Garvy; Sylvie Garneau-Tsodikova; Nishad Thamban Chandrika; Therese J Bocklage; David J Feola
Journal:  Immunobiology       Date:  2020-11-24       Impact factor: 3.144

Review 4.  Pneumocystis Pneumonia: Immunity, Vaccines, and Treatments.

Authors:  Aaron D Gingerich; Karen A Norris; Jarrod J Mousa
Journal:  Pathogens       Date:  2021-02-19

5.  Bias of the Immune Response to Pneumocystis murina Does Not Alter the Ability of Neonatal Mice to Clear the Infection.

Authors:  Cathryn Kurkjian; Melissa Hollifield; David J Feola; Beth A Garvy
Journal:  J Fungi (Basel)       Date:  2021-10-02

6.  A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.

Authors:  Amelia Chiara Trombetta; Stefano Soldano; Paola Contini; Veronica Tomatis; Barbara Ruaro; Sabrina Paolino; Renata Brizzolara; Paola Montagna; Alberto Sulli; Carmen Pizzorni; Vanessa Smith; Maurizio Cutolo
Journal:  Respir Res       Date:  2018-09-24

7.  Prevalence of Pneumocystosis in Sub-Saharan Africa and Helminth Immune Modulation.

Authors:  Luis Fonte; María Ginori; Enrique J Calderón; Yaxsier de Armas
Journal:  J Fungi (Basel)       Date:  2021-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.